A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
for Systemic Sclerosis
Drug: Nemolizumab
Sites in Arlington +1 more location
Sponsor: Galderma R&D
Sex: All·Age: 18+
Code: NCT07047690·Phase 2·Recruiting·Listed Jul 2025
As of September 2026, 61 paid clinical trials are recruiting in Arlington, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .